Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer

NCT06136026 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2023-11-18

No results posted yet for this study

Summary

This is a nationwide cohort study on integrated traditional Chinese and Western medicine for colorectal cancer. The aim is to elucidate the distribution patterns of TCM syndromes in colorectal cancer and colorectal adenoma, reveal the relationship between TCM syndromes and diagnosis, prognosis, and prognosis. Based on biological samples, a phenotypic omics study of TCM syndromes in colorectal cancer and colorectal adenoma is conducted.

Conditions

Sponsors & Collaborators

  • Jiangsu Province Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Fujian Cancer Hospital

    collaborator OTHER_GOV
  • Hubei Cancer Hospital

    collaborator OTHER
  • Shandong Cancer Hospital and Institute

    collaborator OTHER
  • Shanxi Province Cancer Hospital

    collaborator OTHER
  • Sichuan Cancer Hospital and Research Institute

    collaborator OTHER
  • Yunnan Cancer Hospital

    collaborator OTHER
  • Zhejiang Cancer Hospital

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Chongqing University Cancer Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Anhui Medical University

    collaborator OTHER
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • First Affiliated Hospital of Harbin Medical University

    collaborator OTHER
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER
  • Tianjin Medical University Cancer Institute and Hospital

    collaborator OTHER
  • Gansu Cancer Hospital

    collaborator OTHER
  • Jiangsu Famous Medical Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Hai bo Cheng, Professor · Affiliated Hospital of Nanjing University of Chinese Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2028-12-31
Completion
2033-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06136026 on ClinicalTrials.gov